Is Cost Effective Clinical Use of Digital Pathology Possible?

Clinical use of digital pathology remains a very hot topic in the pathology community. Although most pathologists and industry colleagues perceive that there is nothing very new to report since the FDA has not issued any guidance and no whole slide scanners have received Class III approval from the FDA.

Visiopharm is going to change that perception!

The future for clinical use of digital pathology is very bright with image analysis.  You will see great (dare I say… groundbreaking) advances from Visiopharm in 2014 that will address a lot of the challenges anatomic pathology faces with clinical use of digital pathology.  Read more…